DL

Darren Mark Legrand

NA Novartis Ag: 13 patents #212 of 5,128Top 5%
📍 East Grinstead, GB: #4 of 64 inventorsTop 7%
Overall (All Time): #348,691 of 4,157,543Top 9%
14
Patents All Time

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDate
10117858 Pyridine and pyrazine derivative for the treatment of CF Urs Baettig, Kamlesh Jagdis Bala, Emma Budd, Lee Edwards, Catherine Howsham +2 more 2018-11-06
RE46757 Pyridine and pyrazine derivative for the treatment of CF Urs Baettig, Kamlesh Jagdis Bala, Emma Budd, Lee Edwards, Catherine Howsham +2 more 2018-03-20
9763957 Autotaxin inhibitors David Beattie, Urs Baettig, Andrew Stuart Lister, Jeffrey McKenna, David Pearce +3 more 2017-09-19
9409895 Autotaxin inhibitors Vikki Furminger, Christopher Thomson, Owen Rhys Hughes, Emily Stanley 2016-08-09
9365552 Pyridine and pyrazine derivative for the treatment of CF Urs Baettig, Kamlesh Jagdis Bala, Emma Budd, Lee Edwards, Catherine Howsham +2 more 2016-06-14
9056867 N-substituted heterocyclyl carboxamides Kamlesh Jagdis Bala, Emma Budd, Lee Edwards, Catherine Howsham, Roger John Taylor 2015-06-16
9034879 Heterocyclic compounds for the treatment of CF Kamlesh Jagdis Bala, Rebecca Butler, Stephen Paul Collingwood, Edward Charles Hall, Lee Edwards +1 more 2015-05-19
8476269 Pyridine and pyrazine derivative for the treatment of CF Urs Baettig, Kamlesh Jagdis Bala, Emma Budd, Lee Edwards, Catherine Howsham +2 more 2013-07-02
8247436 Pyridine and pyrazine derivative for the treatment of CF Urs Baettig, Kamlesh Jagdis Bala, Emma Budd, Lee Edwards, Catherine Howsham +2 more 2012-08-21
8053574 Organic compounds Ian Bruce, James Dale, Thomas Anthony Hunt 2011-11-08
7998990 5-phenyl-thiazol-2-yl-urea derivatives and use as PI3 kinase inhibitors Emma Budd, Judy Fox Hayler, Ian Bruce, Brian Cox 2011-08-16
7754746 Organic compounds Emma Budd, Julia Doris Ida Hatto, Judy Fox Hayler, Barbara Valade 2010-07-13
7691841 Azetidine derivatives as CCR-3 receptor antagonist 2010-04-06
7482347 Piperazine derivatives with CCR-3 inhibiting activity 2009-01-27